Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus

Tashi Uno, K. Isobe, H. Kawakami, N. Ueno, H. Shimada, H. Matsubara, S. Okazumi, Y. Nabeya, T. Shiratori, T. Kawata, T. Ochiai, H. Ito

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Little is known concerning the role of concurrent chemoradiation (CCRT) in the management of carcinoma of the cervical esophagus. We retrospectively evaluated our treatment approach for patients with cervical esophageal cancer with special emphasis on CCRT with or without surgery. Medical records of 21 consecutive patients with cervical esophageal carcinoma treated mainly with CCRT (1997-2004) were reviewed, and factors that influenced patient survival were analyzed retrospectively. Nineteen received CCRT with cisplatin/5-fluorouracil and five underwent curative surgery. Two patients who were deemed unfit for CCRT received radiation therapy alone. All had three-dimensional treatment planning (median total dose, 40.Gy with surgery, 64.Gy without surgery). Of the 19 patients who received CCRT, 11 patients including five who underwent curative surgery achieved initial local control. Neither of the two patients who received radiation therapy alone achieved local control. Among 19 patients who underwent CCRT, 9/11 with T1-3 grade tumors achieved initial local control, but only 2/8 patients with T4 tumors (P = 0.011, χ2 test) achieved initial local control. No patient without initial local control survived > 20 months compared with 2-year and 5-year survival rates of 605% and 40% in those who achieved initial local control (P = 0.038). No patient with T4 tumors survived > 18 months, whereas 2- and 5-year survival rates were 62% and 41%, respectively, in those with T1-3 tumors (P = 0.006). The significant effect of T-classification on survival was maintained when analyzed among 19 patients who received CCRT. CCRT shows promise for cervical esophageal carcinoma. T-classification and initial local control had significant impact on survival.

Original languageEnglish
Pages (from-to)12-18
Number of pages7
JournalDiseases of the Esophagus
Volume20
Issue number1
DOIs
Publication statusPublished - 2007 Feb
Externally publishedYes

Fingerprint

Esophagus
Squamous Cell Carcinoma
Carcinoma
Survival
Neoplasms
Radiotherapy
Survival Rate
Esophageal Neoplasms
Fluorouracil
Uterine Cervical Neoplasms
Cisplatin
Medical Records

Keywords

  • Cervical esophagus
  • Cisplatin
  • Concurrent chemoradiation
  • Esophageal cancer
  • Radiation therapy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. / Uno, Tashi; Isobe, K.; Kawakami, H.; Ueno, N.; Shimada, H.; Matsubara, H.; Okazumi, S.; Nabeya, Y.; Shiratori, T.; Kawata, T.; Ochiai, T.; Ito, H.

In: Diseases of the Esophagus, Vol. 20, No. 1, 02.2007, p. 12-18.

Research output: Contribution to journalArticle

Uno, T, Isobe, K, Kawakami, H, Ueno, N, Shimada, H, Matsubara, H, Okazumi, S, Nabeya, Y, Shiratori, T, Kawata, T, Ochiai, T & Ito, H 2007, 'Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus', Diseases of the Esophagus, vol. 20, no. 1, pp. 12-18. https://doi.org/10.1111/j.1442-2050.2007.00632.x
Uno, Tashi ; Isobe, K. ; Kawakami, H. ; Ueno, N. ; Shimada, H. ; Matsubara, H. ; Okazumi, S. ; Nabeya, Y. ; Shiratori, T. ; Kawata, T. ; Ochiai, T. ; Ito, H. / Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. In: Diseases of the Esophagus. 2007 ; Vol. 20, No. 1. pp. 12-18.
@article{546648e9ebaa4bdf98c142d2cbc4079d,
title = "Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus",
abstract = "Little is known concerning the role of concurrent chemoradiation (CCRT) in the management of carcinoma of the cervical esophagus. We retrospectively evaluated our treatment approach for patients with cervical esophageal cancer with special emphasis on CCRT with or without surgery. Medical records of 21 consecutive patients with cervical esophageal carcinoma treated mainly with CCRT (1997-2004) were reviewed, and factors that influenced patient survival were analyzed retrospectively. Nineteen received CCRT with cisplatin/5-fluorouracil and five underwent curative surgery. Two patients who were deemed unfit for CCRT received radiation therapy alone. All had three-dimensional treatment planning (median total dose, 40.Gy with surgery, 64.Gy without surgery). Of the 19 patients who received CCRT, 11 patients including five who underwent curative surgery achieved initial local control. Neither of the two patients who received radiation therapy alone achieved local control. Among 19 patients who underwent CCRT, 9/11 with T1-3 grade tumors achieved initial local control, but only 2/8 patients with T4 tumors (P = 0.011, χ2 test) achieved initial local control. No patient without initial local control survived > 20 months compared with 2-year and 5-year survival rates of 605{\%} and 40{\%} in those who achieved initial local control (P = 0.038). No patient with T4 tumors survived > 18 months, whereas 2- and 5-year survival rates were 62{\%} and 41{\%}, respectively, in those with T1-3 tumors (P = 0.006). The significant effect of T-classification on survival was maintained when analyzed among 19 patients who received CCRT. CCRT shows promise for cervical esophageal carcinoma. T-classification and initial local control had significant impact on survival.",
keywords = "Cervical esophagus, Cisplatin, Concurrent chemoradiation, Esophageal cancer, Radiation therapy",
author = "Tashi Uno and K. Isobe and H. Kawakami and N. Ueno and H. Shimada and H. Matsubara and S. Okazumi and Y. Nabeya and T. Shiratori and T. Kawata and T. Ochiai and H. Ito",
year = "2007",
month = "2",
doi = "10.1111/j.1442-2050.2007.00632.x",
language = "English",
volume = "20",
pages = "12--18",
journal = "Diseases of the Esophagus",
issn = "1120-8694",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus

AU - Uno, Tashi

AU - Isobe, K.

AU - Kawakami, H.

AU - Ueno, N.

AU - Shimada, H.

AU - Matsubara, H.

AU - Okazumi, S.

AU - Nabeya, Y.

AU - Shiratori, T.

AU - Kawata, T.

AU - Ochiai, T.

AU - Ito, H.

PY - 2007/2

Y1 - 2007/2

N2 - Little is known concerning the role of concurrent chemoradiation (CCRT) in the management of carcinoma of the cervical esophagus. We retrospectively evaluated our treatment approach for patients with cervical esophageal cancer with special emphasis on CCRT with or without surgery. Medical records of 21 consecutive patients with cervical esophageal carcinoma treated mainly with CCRT (1997-2004) were reviewed, and factors that influenced patient survival were analyzed retrospectively. Nineteen received CCRT with cisplatin/5-fluorouracil and five underwent curative surgery. Two patients who were deemed unfit for CCRT received radiation therapy alone. All had three-dimensional treatment planning (median total dose, 40.Gy with surgery, 64.Gy without surgery). Of the 19 patients who received CCRT, 11 patients including five who underwent curative surgery achieved initial local control. Neither of the two patients who received radiation therapy alone achieved local control. Among 19 patients who underwent CCRT, 9/11 with T1-3 grade tumors achieved initial local control, but only 2/8 patients with T4 tumors (P = 0.011, χ2 test) achieved initial local control. No patient without initial local control survived > 20 months compared with 2-year and 5-year survival rates of 605% and 40% in those who achieved initial local control (P = 0.038). No patient with T4 tumors survived > 18 months, whereas 2- and 5-year survival rates were 62% and 41%, respectively, in those with T1-3 tumors (P = 0.006). The significant effect of T-classification on survival was maintained when analyzed among 19 patients who received CCRT. CCRT shows promise for cervical esophageal carcinoma. T-classification and initial local control had significant impact on survival.

AB - Little is known concerning the role of concurrent chemoradiation (CCRT) in the management of carcinoma of the cervical esophagus. We retrospectively evaluated our treatment approach for patients with cervical esophageal cancer with special emphasis on CCRT with or without surgery. Medical records of 21 consecutive patients with cervical esophageal carcinoma treated mainly with CCRT (1997-2004) were reviewed, and factors that influenced patient survival were analyzed retrospectively. Nineteen received CCRT with cisplatin/5-fluorouracil and five underwent curative surgery. Two patients who were deemed unfit for CCRT received radiation therapy alone. All had three-dimensional treatment planning (median total dose, 40.Gy with surgery, 64.Gy without surgery). Of the 19 patients who received CCRT, 11 patients including five who underwent curative surgery achieved initial local control. Neither of the two patients who received radiation therapy alone achieved local control. Among 19 patients who underwent CCRT, 9/11 with T1-3 grade tumors achieved initial local control, but only 2/8 patients with T4 tumors (P = 0.011, χ2 test) achieved initial local control. No patient without initial local control survived > 20 months compared with 2-year and 5-year survival rates of 605% and 40% in those who achieved initial local control (P = 0.038). No patient with T4 tumors survived > 18 months, whereas 2- and 5-year survival rates were 62% and 41%, respectively, in those with T1-3 tumors (P = 0.006). The significant effect of T-classification on survival was maintained when analyzed among 19 patients who received CCRT. CCRT shows promise for cervical esophageal carcinoma. T-classification and initial local control had significant impact on survival.

KW - Cervical esophagus

KW - Cisplatin

KW - Concurrent chemoradiation

KW - Esophageal cancer

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=33846246230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846246230&partnerID=8YFLogxK

U2 - 10.1111/j.1442-2050.2007.00632.x

DO - 10.1111/j.1442-2050.2007.00632.x

M3 - Article

VL - 20

SP - 12

EP - 18

JO - Diseases of the Esophagus

JF - Diseases of the Esophagus

SN - 1120-8694

IS - 1

ER -